Add to ORKGIntroduction: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonly dysregulated in PCA. As a proof-of-principle study, we aimed to evaluate the potential of fecal miRNAs as biomarkers for pancreatic cancer. Materials and Methods: Total RNA was extracted from feces using Qiagen’s miRNA Mini Kit. For miRNA expression analyse
Background MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, there...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and hi...
microRNAs (miRNAs) have been reported to be aberrantly expressed in patients with pancreatic cancer....
INTRODUCTION: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rat...
Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority o...
<p>(A) MiRNA microarray expression analyses were performed using Illumina microarray to evaluate the...
Pancreatic cancer is the fourth cause of the death by cancer worldwide. It remains the only cancer w...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Background Pancreatic cancer is the fourth leading cause of cancer death in Western countries, with ...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Recently, several microRNAs (miRNAs) have been reported as promising biomarkers for cancer detection...
IMPORTANCE: Biomarkers for the early diagnosis of patients with pancreatic cancer are needed to impr...
Ductal adenocarcinoma (PDAC) is the most common primary pancreatic neoplasm. It's frequently diagnos...
Pancreatic ductal adenocarcinoma (PDAC), a rare but lethal tumor, is difficult to diagnose without p...
Background MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, there...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and hi...
microRNAs (miRNAs) have been reported to be aberrantly expressed in patients with pancreatic cancer....
INTRODUCTION: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rat...
Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority o...
<p>(A) MiRNA microarray expression analyses were performed using Illumina microarray to evaluate the...
Pancreatic cancer is the fourth cause of the death by cancer worldwide. It remains the only cancer w...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Background Pancreatic cancer is the fourth leading cause of cancer death in Western countries, with ...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Recently, several microRNAs (miRNAs) have been reported as promising biomarkers for cancer detection...
IMPORTANCE: Biomarkers for the early diagnosis of patients with pancreatic cancer are needed to impr...
Ductal adenocarcinoma (PDAC) is the most common primary pancreatic neoplasm. It's frequently diagnos...
Pancreatic ductal adenocarcinoma (PDAC), a rare but lethal tumor, is difficult to diagnose without p...
Background MicroRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis, and cell growth, there...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and hi...
microRNAs (miRNAs) have been reported to be aberrantly expressed in patients with pancreatic cancer....